Published in Lancet on July 16, 1977
Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev (2006) 4.46
Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. BMJ (1996) 3.79
Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation (2010) 3.37
Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation (2011) 2.45
Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci U S A (2012) 2.42
Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity (2013) 2.37
Control of splenic bleeding during splenic flexure mobilisation by devascularisation of the inferior pole of the spleen. Tech Coloproctol (2012) 2.02
Vascular complications after splenectomy for hematologic disorders. Blood (2009) 1.89
Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res (2010) 1.82
Management of injury to the spleen in adults. Results of early operation and observation. Ann Surg (1984) 1.74
Pneumococcal vaccination and risk of myocardial infarction. CMAJ (2008) 1.61
Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut (1995) 1.52
The spleen in local and systemic regulation of immunity. Immunity (2013) 1.33
B cells and humoral immunity in atherosclerosis. Circ Res (2014) 1.25
Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up. Haematologica (2013) 1.14
Evolving concepts in splenic surgery: splenorrhaphy versus splenectomy and postsplenectomy drainage: experience in 105 patients. Ann Surg (1981) 1.09
Nonoperative management of adult blunt splenic trauma. Criteria for successful outcome. Ann Surg (1989) 1.04
Hazards of hyposplenism. Br Med J (Clin Res Ed) (1982) 1.04
The spleen? Who needs it anyway? Clin Exp Immunol (1992) 1.03
Blunt transection of the pancrease treated by distal pancreatectomy, splenic salvage and hyperalimentation. Four cases and review of the literature. Ann Surg (1982) 1.00
Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure. Circ Res (2016) 0.99
Impaired antipneumococcal antibody production in patients without spleens. Br Med J (Clin Res Ed) (1985) 0.96
Evaluation of splenic embolization in patients with portal hypertension and hypersplenism. Ann Surg (1982) 0.95
Autosplenectomy in severity of sickle cell diseases. Int J Clin Exp Med (2014) 0.91
Blood viscosity after splenectomy. Br Med J (Clin Res Ed) (1981) 0.91
Splenorrhaphy. The alternative. Ann Surg (1990) 0.90
Expanding spectrum of the association between Type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types--correlation with genotype and phenotype. Am J Hematol (2010) 0.87
Histopathologic evaluation of lung and extrapulmonary tissues show sex differences in Klebsiella pneumoniae - infected mice under different exposure conditions. Int J Physiol Pathophysiol Pharmacol (2011) 0.86
Hereditary spherocytosis and partial splenectomy in children: review of surgical technique and the role of imaging. Pediatr Radiol (2010) 0.85
Coeliac disease, splenic function, and malignancy. Gut (1982) 0.85
Pylorus- and spleen-preserving total pancreatoduodenectomy with resection of both whole splenic vessels: feasibility and laparoscopic application to intraductal papillary mucin-producing tumors of the pancreas. Surg Endosc (2012) 0.84
SIRPα/CD172a and FHOD1 are unique markers of littoral cells, a recently evolved major cell population of red pulp of human spleen. J Immunol (2012) 0.84
Twenty years of splenic preservation in trauma: lower early infection rate than in splenectomy. World J Surg (2008) 0.83
Splenic influence on the development of a local pulmonary immune response. Infect Immun (1979) 0.83
Splenic immunity and atherosclerosis: a glimpse into a novel paradigm? J Clin Invest (2002) 0.83
Splenectomy inhibits non-small cell lung cancer growth by modulating anti-tumor adaptive and innate immune response. Oncoimmunology (2015) 0.82
Proteomics identifies multipotent and low oncogenic risk stem cells of the spleen. Int J Biochem Cell Biol (2009) 0.82
Blunt splenic injury in Sikkimese children and adolescents. J Emerg Trauma Shock (2011) 0.82
Increased susceptibility of splenectomized mice to infection after exposure to an aerosolized suspension of type III Streptococcus pneumoniae. Infect Immun (1978) 0.80
Leukocyte-Expressed β2-Adrenergic Receptors Are Essential for Survival After Acute Myocardial Injury. Circulation (2016) 0.80
Sterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell response. Proc Natl Acad Sci U S A (2015) 0.79
Traditional laboratory measures of cardiovascular risk in hereditary spherocytosis. Pediatr Blood Cancer (2010) 0.78
A defective Th1 response of the spleen in the initial phase may explain why splenectomy helps prevent a Listeria infection. Clin Exp Immunol (2005) 0.78
Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity. Immunol Rev (2016) 0.78
Laparoscopic partial splenectomy is safe and effective in patients with focal benign splenic lesion. Surg Endosc (2014) 0.78
Updating the management of salvageable splenic injury. Ann Surg (1992) 0.77
Long-term risk of acute coronary syndrome in splenectomized patients due to splenic injury. Medicine (Baltimore) (2015) 0.76
The immunology of atherosclerosis. Nat Rev Nephrol (2017) 0.75
Spinal Cord Infarction in a Patient with Hereditary Spherocytosis: A Case Report and Discussion. Case Rep Neurol Med (2016) 0.75
Splenectomy. Can Med Assoc J (1979) 0.75
Hepatocellular carcinoma complicating chronic granulomatous hepatitis. J Clin Pathol (1983) 0.75
Post splenectomy fatal pulmonary embolism in a patient with moderate hemophilia a. Iran J Med Sci (2011) 0.75
The spleen preserved. Br Med J (Clin Res Ed) (1984) 0.75
Long-term complications of splenectomy in adult immune thrombocytopenia. Medicine (Baltimore) (2016) 0.75
Feasibility and safety of emergency laparoscopic partial splenectomy: A retrospective analysis. Medicine (Baltimore) (2017) 0.75
Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques. PLoS One (2016) 0.75
Malign effects of splenectomy--the place of conservative treatment. Postgrad Med J (1982) 0.75
Hematologic improvement following splenectomy for hemoglobin-H disease. West J Med (1982) 0.75
Recommendations for splenectomy in hereditary hemolytic anemias. Haematologica (2017) 0.75
Stage-dependent detection of CD14+ and CD16+ cells in the human heart after myocardial infarction. Virchows Arch (2013) 0.75
Risk of cardiovascular events and pulmonary hypertension following splenectomy - a Danish population-based cohort study from 1996-2012. Haematologica (2017) 0.75
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96
Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med (1969) 6.54
A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (1999) 5.09
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
Snuff dipping and oral cancer among women in the southern United States. N Engl J Med (1981) 4.33
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med (2000) 3.72
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA (1986) 3.63
Risk of cancer in renal-transplant recipients. Lancet (1973) 3.36
Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30
Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
The Vietnam Era Twin (VET) Registry: method of construction. Acta Genet Med Gemellol (Roma) (1987) 3.18
A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00
Clues to cancer etiology from studies of farmers. Scand J Work Environ Health (1992) 2.98
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76
Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA (1993) 2.71
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol (1998) 2.65
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
A population-based case-control study of childhood leukemia in Shanghai. Cancer (1988) 2.59
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst (1969) 2.50
International trends and patterns of primary liver cancer. Int J Cancer (2001) 2.50
Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol (1991) 2.49
Geographic patterns of lung cancer: industrial correlations. Am J Epidemiol (1976) 2.45
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (1998) 2.43
Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev (2002) 2.36
Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst (2000) 2.32
Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol (2001) 2.30
Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst (1969) 2.30
Declining lung cancer rates among young men and women in the United States: a cohort analysis. J Natl Cancer Inst (1989) 2.28
Cancer mortality among chemists. J Natl Cancer Inst (1969) 2.28
Acute leukemia after alkylating-agent therapy of ovarian cancer. N Engl J Med (1977) 2.20
Fluoridated drinking water and the occurrence of cancer. J Natl Cancer Inst (1976) 2.19
A population--based case--control study of renal cell carcinoma. J Natl Cancer Inst (1984) 2.17
Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst (1998) 2.13
Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2001) 2.13
Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst (1997) 2.12
Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst (1987) 2.12
Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst (1976) 2.11
Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int J Cancer (1994) 2.09
Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst (1997) 2.06
Synthetic sweetener consumption and bladder cancer trends in the United States. Nature (1970) 2.05
The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China. Cancer (1996) 2.05
Geographic patterns of oral cancer in the United States: etilogic implications. J Chronic Dis (1977) 2.02
Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst (1987) 2.02
Solid tumors after chronic lymphocytic leukemia. Blood (2001) 2.01
Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst (1987) 2.01
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control (2000) 2.00
Passive smoking and lung cancer. J Natl Cancer Inst (1986) 1.99
Smoking, air pollution, and the high rates of lung cancer in Shenyang, China. J Natl Cancer Inst (1989) 1.99
A population-based case-control study of thyroid cancer. J Natl Cancer Inst (1987) 1.98
Epidemiology of uterine cervical cancer. J Chronic Dis (1986) 1.97
Epidemiology of human leukemia: recent observations. J Natl Cancer Inst (1967) 1.97
Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev (2001) 1.95
Indoor radon and lung cancer in China. J Natl Cancer Inst (1990) 1.95
Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst (1998) 1.91
Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res (1991) 1.89
Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer (2007) 1.87
Lung cancer among Chinese women. Int J Cancer (1987) 1.83
Tobacco and alcohol use and oral cancer in Puerto Rico. Cancer Causes Control (1999) 1.83
Cancer incidence trends in urban shanghai, 1972-1994: an update. Int J Cancer (1999) 1.83
Lung cancer after employment in shipyards during World War II. N Engl J Med (1978) 1.82
Breast cancer risk factors among screening program participants. J Natl Cancer Inst (1979) 1.81
Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco, and other determinants. J Natl Cancer Inst (1993) 1.80
Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst (1992) 1.79
The Vietnam Era Twin (VET) Registry: ascertainment bias. Acta Genet Med Gemellol (Roma) (1987) 1.78
The study of human twins in medical research. N Engl J Med (1984) 1.75
Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer (1993) 1.75
Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst (1994) 1.74
Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. JAMA (1978) 1.74
A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). Cancer Causes Control (1993) 1.74
Cancer mortality in U.S. counties with chemical industries. Environ Res (1975) 1.74
Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer (2000) 1.73
The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature (2001) 1.71
Urinary tract infection and risk of bladder cancer. Am J Epidemiol (1984) 1.70
Prospective study of a family cancer syndrome. JAMA (1982) 1.69
A cohort study of stomach cancer in a high-risk American population. Cancer (1991) 1.67
Cancer among epileptic patients exposed to anticonvulsant drugs. J Natl Cancer Inst (1989) 1.66
Linxian nutrition intervention trials. Design, methods, participant characteristics, and compliance. Ann Epidemiol (1993) 1.66
Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med (1985) 1.64
Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst (1995) 1.62
The epidemiology of soft tissue sarcoma. Semin Oncol (1997) 1.62
Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst (1987) 1.62
Cancer in the parents of children with cancer. N Engl J Med (1995) 1.61
Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer (1999) 1.60